Compile Data Set for Download or QSAR
maximum 50k data
Found 2358 with Last Name = 'dong' and Initial = 'q'
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50285024(3-[3-(4-Carbamimidoyl-benzoylamino)-propionylamino...)
Affinity DataKi:  2.10nMAssay Description:Displacement of [3H]-SKF-107260 from alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
TBA

Curated by ChEMBL
LigandPNGBDBM50285023((R)-3-[3-(4-Carbamimidoyl-benzoylamino)-propionyla...)
Affinity DataKi:  2.30nMAssay Description:Displacement of [3H]-SKF-107260 from alpha IIb beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
Target4-hydroxy-tetrahydrodipicolinate reductase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59098(Bi-ligand, 1)
Affinity DataKi:  26nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetQuinone-dependent D-lactate dehydrogenase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59099(Bi-ligand, 2)
Affinity DataKi:  42nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target4-hydroxy-tetrahydrodipicolinate reductase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59101(Bi-ligand, 4)
Affinity DataKi:  100nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1-deoxy-D-xylulose 5-phosphate reductoisomerase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59100(Bi-ligand, 3)
Affinity DataKi:  202nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetQuinone-dependent D-lactate dehydrogenase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59101(Bi-ligand, 4)
Affinity DataKi:  620nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1-deoxy-D-xylulose 5-phosphate reductoisomerase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59101(Bi-ligand, 4)
Affinity DataKi:  7.90E+3nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target1-deoxy-D-xylulose 5-phosphate reductoisomerase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59099(Bi-ligand, 2)
Affinity DataKi:  1.00E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetQuinone-dependent D-lactate dehydrogenase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59100(Bi-ligand, 3)
Affinity DataKi:  1.20E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target4-hydroxy-tetrahydrodipicolinate reductase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59100(Bi-ligand, 3)
Affinity DataKi: >2.50E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target4-hydroxy-tetrahydrodipicolinate reductase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59099(Bi-ligand, 2)
Affinity DataKi: >5.00E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Target1-deoxy-D-xylulose 5-phosphate reductoisomerase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59098(Bi-ligand, 1)
Affinity DataKi: >5.00E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetQuinone-dependent D-lactate dehydrogenase(Escherichia coli)
Triad Therapeutics

LigandPNGBDBM59098(Bi-ligand, 1)
Affinity DataKi:  5.50E+4nMpH: 7.4Assay Description:All reactions were monitored spectrophotometrically at 340 nm by using initial rates from the first 5% of reaction.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM439612(1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)met...)
Affinity DataIC50:  0.110nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405268(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.110nMAssay Description:Human: Test Example 1. Human GnRHr (GnRH Receptor) Activity Assay of the Present Compounds.In vitro GnRHr protein activity was tested by the followin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605909(US11680056, Example 53A | US11680056, Example 53B)
Affinity DataIC50:  0.126nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMAssay Description:JAK1: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605939(US11680056, Example 68B)
Affinity DataIC50:  0.200nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMAssay Description:JAK1: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.200nMAssay Description:JAK1: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260478(US10428074, Example 125 | US9527851, 125 | US95278...)
Affinity DataIC50:  0.200nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Rabbit)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405272(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.240nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG_PROTEIN_RECEP_F1_2 domain-containing protein(Oryctolagus cuniculus (Rabbit))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405272(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.240nMAssay Description:Rabbit: This assay was used to determine the inhibition effect of the present compounds on the activity of rabbit GnRHr protein expressed by rabbit G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone II receptor(Green monkey)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405272(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.240nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Rabbit)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405271(1-(4-(3-((dimethylamino)methyl)-5-(2-fluoro-3-meth...)
Affinity DataIC50:  0.270nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetG_PROTEIN_RECEP_F1_2 domain-containing protein(Oryctolagus cuniculus (Rabbit))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405271(1-(4-(3-((dimethylamino)methyl)-5-(2-fluoro-3-meth...)
Affinity DataIC50:  0.270nMAssay Description:Rabbit: This assay was used to determine the inhibition effect of the present compounds on the activity of rabbit GnRHr protein expressed by rabbit G...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.300nMAssay Description:JAK3: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK3 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM202489(US9527851, example 99)
Affinity DataIC50:  0.300nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.300nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK3 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260502(US9527851, 99)
Affinity DataIC50:  0.300nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260459(US10428074, Example 17 | US9527851, 17 | US9527851...)
Affinity DataIC50:  0.300nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK3 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM415495(US10428074, Example 99)
Affinity DataIC50:  0.300nMAssay Description:JAK1: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMAP kinase-activated protein kinase 5 Isoform 2(Homo sapiens (Human))
Xinthera

US Patent
LigandPNGBDBM605929(US11680056, Example 63B)
Affinity DataIC50:  0.316nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405272(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.420nMAssay Description:Human: Test Example 1. Human GnRHr (GnRH Receptor) Activity Assay of the Present Compounds.In vitro GnRHr protein activity was tested by the followin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405272(1-(4-(7-(2,6-difluorobenzyl)-3-((dimethylamino)met...)
Affinity DataIC50:  0.420nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405278(1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)met...)
Affinity DataIC50:  0.430nMAssay Description:Human: Test Example 1. Human GnRHr (GnRH Receptor) Activity Assay of the Present Compounds.In vitro GnRHr protein activity was tested by the followin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405278(1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)met...)
Affinity DataIC50:  0.430nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405270(1-(4-(3-((dimethylamino)methyl)-5-(2-fluoro-3-meth...)
Affinity DataIC50:  0.490nMAssay Description:Human: Test Example 1. Human GnRHr (GnRH Receptor) Activity Assay of the Present Compounds.In vitro GnRHr protein activity was tested by the followin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGonadotropin-releasing hormone receptor(Homo sapiens (Human))
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM405270(1-(4-(3-((dimethylamino)methyl)-5-(2-fluoro-3-meth...)
Affinity DataIC50:  0.490nMAssay Description:In vitro GnRHr protein activity was tested by the following methods.This assay was used to determine the inhibition effect of the present compound on...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204291(CHEMBL3953104 | US20230295171, Example 76)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM260479(US9527851, 50)
Affinity DataIC50:  0.5nMpH: 7.3 T: 2°CAssay Description:In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The test ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM202338((3ar,5s,6as)-n-(3-(hydroxymethyl)-1,2,4-thiadiazol...)
Affinity DataIC50:  0.5nMpH: 7.3 T: 2°CAssay Description:TBDIn vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The te...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK1(Homo sapiens (Human))
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM415473((3aR,5S,6aS)?N-(3-(Hydroxymethyl)-1,2,4-thiadiazol...)
Affinity DataIC50:  0.5nMAssay Description:JAK1: In vitro kinase assays described below can be used to determine the activity of a test compound for inhibiting the activity of JAK1 kinase. The...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204291(CHEMBL3953104 | US20230295171, Example 76)
Affinity DataIC50:  0.501nMAssay Description:YK protein is prepared from cDNA encoding human spleen tyrosine kinase and is expressed in insect cells using a baculovirus expression vector. The cD...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 2358 total ) | Next | Last >>
Jump to: